Gravar-mail: COMBINATION TREATMENT OF STROKE WITH SUB-THERAPEUTIC DOSES OF SIMVASTATIN AND HUMAN UMBILICAL CORD BLOOD CELLS ENHANCES VASCULAR REMODELING AND IMPROVES FUNCTIONAL OUTCOME